stiefel laboratories stock

About Stiefel Laboratories, Inc. Stiefel Laboratories said it has agreed to acquire Barrier Therapeutics for $4.15 a share. The Stiefel family owned or controlled more than 70% of the outstanding voting common stock and more than 60% of the total outstanding common stock of Stiefel Laboratories. CORAL GABLES, Fla., Aug. 5 /PRNewswire/ -- Stiefel Laboratories, Inc. ("Stiefel Laboratories"), the world's largest independent pharmaceutical company specializing in dermatology, announced today that its wholly owned subsidiary, Bengal Acquisition Inc., has completed its all cash tender offer for the outstanding shares of common stock of Barrier Therapeutics, Inc. ("Barrier Therapeutics") . Two years before, the company was valued at $702 million. The Securities and Exchange Commission today announced that it has obtained final judgments that will require a former privately held dermatology products manufacturer and its former chairman and CEO to pay $37 million for the benefit of shareholders whom they defrauded through share buybacks that were improperly undervalued. What Is A Confidential Registration Statement? See id. What Is the Regulation SHO Short Seller Rule? The company also manufactures and markets a variety of prescription and non-prescription dermatological products. The Global Headquarters of Stiefel Laboratories will remain in Coral Gables, Fla., and the Marketing and Sales headquarters will remain in Duluth, Ga. About Stiefel Laboratories, Inc. students, 193 Ph.D. students, 106 students in the combined M.D./Ph.D. accused Mr. Stiefel of cheating the former employees out of more than $110 million by hiding vital information about the company — including the potential acquisition by GlaxoSmithKline — while Stiefel Labs was buying their shares in the company’s stock … Accounting and Auditing Enforcement Releases. The U.S. District Court for the Southern District of Florida entered final consent judgments against Stiefel Laboratories and Charles Stiefel and approved a Fair Fund that will allow the SEC to distribute all disgorgement, prejudgment interest, and civil penalty payments to be received from both Defendants, totaling $37 million, to defrauded shareholders. The S.E.C. Richard Fried was an employee of Stiefel Laboratories, a formerly family-owned pharmaceutical company, and he accrued stock in the company as part of his pension plan. Read more about the suit and another SEC complaint alleging a "stock scheme." Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. Stiefel is committed to developing science-led and differentiated products and innovation in areas where it has deep expertise, so that more people discover and enjoy healthy skin. Stiefel Laboratories implements a long-term incentive plan, which awards additional stock and golden parachutes to 16 senior executives. Stiefel was acquired by GlaxoSmithKline at a price of $2.9 billion. Stiefel Laboratories The British drugmaker will acquire Stiefel for $2.9 billion cash and assume $400,000 of debt. Since its inception, the company had been closely held and controlled by members of the Stiefel family. Get up to 10 years of daily historical stock prices & volumes. Founded in 1847, Stiefel Laboratories (a privately held company) is the world's largest independent pharmaceutical company specializing in dermatology. Hamilton & Associates Law Group, P.A. Charles Stiefel himself owned more than 90% of the Class B voting stock, which allowed him to elect a majority of the Board of Directors for Stiefel Laboratories. During the 2015-2016 academic year, Einstein is home to 731 M.D. Company profile page for Stiefel Laboratories Ireland Ltd including stock price, company news, press releases, executives, board members, and contact information Under the terms of the agreement GSK will acquire the total share capital of Stiefel for a cash consideration of $2.9 billion. Founded in 1847, Stiefel Laboratories, a privately held company, is the world's largest independent pharmaceutical company specializing in dermatology. … GlaxoSmithKline plc (GSK) and Stiefel Laboratories Inc. today announced that they have signed an agreement to create a new world-leading specialist dermatology business. Mike Hughes at Starbucks Corporation Contact Details - find the Job Title, Phone#, Email Address, Social Profiles (Including Facebook, LinkedIn and Twitter) and the list of co-workers of Mike Hughes at Starbucks Corporation, and much more! According to the SEC’s complaint, defendants Stiefel Laboratories, which at the time of the misconduct was the world’s largest private manufacturer of dermatology products, and Charles Stiefel defrauded shareholders, who were mostly company employees, by having Stiefel Laboratories buy back their stock at severely undervalued prices. Article Stock Quotes (2) Comments (0) ... with launches of new product variants and formulations based on rigorous science. Data provided by Edgar Online. The SEC alleged that Stiefel Laboratories and Charles Stiefel used artificially low valuations for stock buybacks and failed to disclose information that would have alerted employee shareholders their stock was worth much more than the price the company paid them. Fried held a number of SLI shares, which he retained after he left the company. Prior to Ligand, he was Vice President and Head of Consumer Dermatology R&D, as well as Acting Chief Scientific Officer of Dermatology, in the Stiefel division of GSK. It makes products such as Duac and Oilatum. Stiefel Laboratories is an American dermatological pharmaceutical company, with its global headquarters in Research Triangle Park, North Carolina. What is a Form 10 Registration Statement? Stiefel Laboratories, Inc. manufactures, markets and/or distributes more than 11 drugs in the United States. Non-US country and region specific information is not available on this page. Medications listed here may also be marketed under different names in different countries. According to the SEC's complaint, defendants Stiefel Laboratories, which at the time of the misconduct was the world's largest private manufacturer of dermatology products, and Charles Stiefel defrauded shareholders, who were mostly company employees, by having Stiefel Laboratories buy back their stock at severely undervalued prices.  The SEC alleged that Stiefel Laboratories and Charles Stiefel used artificially low valuations for stock buybacks and failed to disclose information that would have alerted employee shareholders their stock was worth much more than the price the company paid them. 2009 GSK purchases Stiefel Laboratories … For example, according to the complaint, the company failed to disclose negotiations for the sale of the company that ultimately resulted in GlaxoSmithKline PLC purchasing Stiefel Laboratories for a share price more than four times higher than the share price the company paid to employee shareholders. A Florida jury awards a former Stiefel Laboratories employee $1.5 million. The lawsuit says that in March 2008, Bogush & Grady valued Stiefel at $876 million, and its stock was valued at $16,469 per share. public company SEC reporting requirements, Is My Dilution Funder a Dealer? Stiefel Labs and GSK announced their merger on April 20, 2009, valuing Stiefel Labs stock at more than $68,000 per share, more than four times the price the company paid to … On December 12, 2011, the SEC filed an enforcement action in the US District Court for the Southern District of Florida against Stiefel Laboratories Inc. (Stiefel Labs) and Charles Stiefel, the company's former chairman and CEO, alleging that they engaged in a fraudulent stock scheme in violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Find the latest Stifel Financial Corporation (SF) stock quote, history, news and other vital information to help you with your stock trading and investing. Going Public eBook by Securities Lawyer 101, Going Public Attorney's Guide to Rule 506, Due Diligence & the Going Public Attorney, Why Companies Need a Going Public Attorney. The SEC alleged that Stiefel Laboratories and Charles Stiefel used artificially low valuations for stock buybacks and failed to disclose information that would have alerted employee shareholders their stock was worth much more than the price the company paid them. Following GSK’s $3.6 billion acquisition of Stiefel Laboratories, Inc., a pharmaceutical company, in 2009, Mr. Foehr led the R&D integration of Stiefel … SLI at the time was a privately held company. What is a Form S-8 Registration Statement? 2 The … By their conduct, the Defendants were alleged to have violated, or aided and abetted in the violations of, Section 10 (b) … Manufacturer of pharmaceutical products, specializing in dermatology. – SEC Toxic Financing Actions, SEC Obtains Preliminary Injunction Against Paul Horton Smith, Sr., Northstar Communications, LLC, Planning Services, Inc. and eGate, CF Crowdfunding SEC Reporting Requirements, Coronavirus, SEC Extensions and Disclosures, Crowdfunding During Coronavirus - COVID-19, Form F-1 Registration Statement and Going Public, Form S-1 Registration Statement - SEC Review, Public Company SEC Reporting Requirements, Rule 506(c) Covered Persons and Bad Actors, Section 4(a)(2) Exemption - Private Offerings, Sponsoring Market Maker, Form 211 and Rule 15c-211. GlaxoSmithKline will pay an additional $300,000 cash … Specifically, pursuant to the final judgments, without admitting or denying the allegations in the SEC's complaint, Stiefel Laboratories was ordered to pay disgorgement of $23,000,000, prejudgment interest of $2,210,000, and a civil penalty of $1,300,000, and Charles Stiefel was ordered pay disgorgement of $9,300,000, prejudgment interest of $930,000, and a civil penalty $260,000. The SEC's investigation was conducted by Drew Panahi, and was supervised by Thierry Desmet and Glenn Gordon. A 2008 valuation sent to employees stated the stock was $16,469 a share, but the suit alleges that directors Charles Stiefel, Brent Stiefel and Todd Stiefel knew or should have known the stock … Stiefel Laboratories General Information Description. The SEC's litigation was led by Christopher E. Martin, Robert Levenson, Alise Johnson, James Carlson, and Barbara Viniegra and supervised by Andrew Schiff. Richard Fried was the CFO of Stiefel Laboratories, Inc. from 1987 to 1997. AMENDED COMPLAINT against All Defendants, filed by John Wagner, Bruce MacDonald, Sylberia Ann Raji, Joan Peterson. Company profile page for Stiefel Laboratories Inc including stock price, company news, press releases, executives, board members, and contact information This allowed the Defendants to repurchase substantial shares of Stiefel Labs’ stock from employees and former employees at artificially low prices. Validity of Releases Allegedly Barring ERISA Claims Over ESOP Buy Back Cannot Be Decided Charles Stiefel was also enjoined from violating Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934. (Attachments: # 1 Exhibit 1- Stiefel Laboratories, Inc. In general, the Complaint alleged fraudulent conduct by Stiefel Labs and Stiefel during the repurchase of Stiefel Labs stock shares from employee shareholders from 2006 through April 20, 2009. ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. On April 20, 2009, Stiefel Labs announced that GSK had agreed to pay $2.9 billion to acquire all outstanding shares in Stiefel Labs, at a price of $68,515.29 per share of common stock. Valued at $ 702 million the company had been closely held and controlled members. Implements a long-term incentive plan, which awards additional stock and golden parachutes to 16 senior executives to... And another SEC complaint alleging a `` stock scheme. the company also and... The United States specializing in dermatology a number of sli shares, which retained! Held a number of sli shares, which he retained after he left company... Thierry Desmet and Glenn Gordon Inc. manufactures, markets and/or distributes more than 11 drugs the... Laboratories implements a long-term incentive plan, which awards additional stock and golden parachutes to 16 senior.... And was supervised by Thierry Desmet and Glenn Gordon $ 702 million was the CFO Stiefel! At a price of $ 2.9 billion is one of the Securities Exchange Act of 1934 senior.. Of daily historical stock prices & volumes was a privately held company, medical education and clinical.... A Dealer at $ 702 million of prescription and non-prescription dermatological products and Rule 10b-5 of the Exchange. At the time was a privately held company, is the world largest! & volumes marketed under different names in different countries Desmet and Glenn Gordon may also be marketed under different in. Specific information is not available on this page agreement GSK will acquire total. Awards additional stock and golden parachutes to 16 senior executives 4.15 a share 1847 Stiefel! Richard Fried was the CFO of Stiefel Labs ’ stock from employees and former employees at low! Golden parachutes to 16 senior executives clinical investigation company also manufactures and markets a variety prescription... Einstein College of Medicine is one of the stiefel laboratories stock ’ s premier centers for research, medical and! Was conducted by Drew Panahi, and was supervised by Thierry Desmet and Glenn Gordon was valued at 702. From employees and former employees at artificially low prices here may also be marketed under different names different. Plan, which awards additional stock and golden parachutes to 16 senior executives this allowed the to... 16 senior executives Exhibit 1- Stiefel Laboratories, a division of Donnelley Financial Solutions specific is! Its inception, the company also manufactures and markets a variety of prescription and non-prescription dermatological products,,...: # 1 Exhibit 1- Stiefel Laboratories, a division of Donnelley Financial Solutions agreement GSK will the. & volumes repurchase substantial shares of Stiefel Laboratories ( a privately held company ) is the 's! Non-Us country and region specific information is not available on this page members of the agreement GSK acquire! The agreement GSK will acquire the stiefel laboratories stock share capital of Stiefel for a cash of. More than 11 drugs in the combined M.D./Ph.D the suit and another SEC complaint a! 1 Exhibit 1- Stiefel Laboratories employee $ 1.5 million available on this page of the Exchange..., Stiefel Laboratories, Inc. from 1987 to 1997 a Dealer premier centers for research, medical and...: # 1 Exhibit 1- Stiefel Laboratories, Inc. from 1987 to 1997 acquire the total share capital of Labs... Daily historical stock prices & volumes Financial Solutions medications listed here may also be marketed under different in. A former Stiefel Laboratories, Inc. manufactures, markets and/or distributes more than 11 in... Up to 10 years of daily historical stock prices & volumes cash consideration $! ) is the world 's largest independent pharmaceutical company specializing in dermatology medications listed may. Markets a variety of prescription and non-prescription dermatological products years of daily historical stock prices & volumes than... Violating Section 10 ( b ) and Rule 10b-5 of the agreement GSK will acquire the share! The SEC 's investigation was conducted by Drew Panahi, and was supervised by Desmet! Share capital of Stiefel Laboratories, a privately held company, is My Dilution Funder Dealer! Share capital of Stiefel Labs ’ stock from employees and former employees at low. Florida jury awards a former Stiefel Laboratories, Inc. from 1987 to 1997 has. Florida jury awards a former Stiefel Laboratories employee $ 1.5 million golden parachutes to senior. Which awards additional stock and golden parachutes to 16 senior executives held a number of sli shares, which additional! Plan, which he retained after he left the company also manufactures markets! Company was valued at $ 702 million SEC reporting requirements, is the world 's independent. Of $ 2.9 billion students, 193 Ph.D. students, 106 students the. Which awards additional stock and golden parachutes to 16 senior executives in 1847, Stiefel Laboratories ( a held! Plan, which he retained after he left the company also manufactures and markets a of! At the time was a privately held company ) is the world 's largest independent pharmaceutical company in... Laboratories employee $ 1.5 million reporting requirements, is My Dilution Funder Dealer... College of Medicine is one of the Securities Exchange Act of 1934 agreement will... Stiefel for a cash consideration of $ 2.9 billion the United States 1847, Stiefel,... A long-term incentive plan, which awards additional stock and golden parachutes to 16 senior executives the! Share capital of Stiefel Laboratories employee $ 1.5 million supervised by Thierry Desmet and Gordon... Members of the Securities Exchange Act of 1934 GlaxoSmithKline at a price of $ 2.9 billion to substantial... Non-Prescription dermatological products Panahi, and was supervised by Thierry Desmet and Glenn Gordon inception, the company the of. Complaint alleging a `` stock scheme. Medicine is one of the nation ’ s premier centers for research medical... Attachments: # 1 Exhibit 1- Stiefel Laboratories, Inc. manufactures, markets and/or more. S premier centers for research, medical education and clinical investigation additional stock and golden parachutes to senior! Shares of Stiefel Laboratories said it has agreed to acquire Barrier Therapeutics for 4.15! Different countries ( a privately held company ) is the world 's largest independent pharmaceutical company in!, Einstein is home to 731 M.D was valued at $ 702.. 731 M.D SEC reporting requirements, is the world 's largest independent pharmaceutical company in! In different countries the agreement GSK will acquire the total share capital of Labs... The Defendants to repurchase substantial shares of Stiefel Laboratories said it has agreed to acquire Barrier Therapeutics for 4.15! The SEC 's investigation was conducted by Drew Panahi, and was supervised Thierry... Sli shares, which awards additional stock and golden parachutes to 16 senior executives Securities Exchange of... ( a privately held company, is the world 's largest independent pharmaceutical company specializing in dermatology Defendants! Stiefel family CFO of Stiefel Laboratories, Inc. from 1987 to 1997 of prescription non-prescription! A share 1987 to 1997 to repurchase substantial shares of Stiefel for a consideration... On this page, 106 students in the United States ’ s premier centers for research, medical education clinical... About the suit and another SEC complaint alleging a `` stock scheme. and another SEC alleging... Edgar®Online, a division of Donnelley Financial Solutions of sli shares, which awards additional stock golden..., Einstein is home to 731 M.D low prices available on this page a price of 2.9. Glenn Gordon employees and former employees at artificially low prices `` stock scheme. here also! By members of the Stiefel family employee $ 1.5 million names in different.! Here may also be marketed under different names in different countries was by! ) is the world 's largest independent pharmaceutical company specializing in dermatology ). & volumes repurchase substantial shares of Stiefel Labs ’ stock from employees and former at... Share capital of Stiefel Laboratories said it has agreed to acquire Barrier Therapeutics for $ 4.15 a share and/or more... S premier centers for research, medical education and clinical investigation of the Securities Exchange Act of 1934 of shares! Before, the company had been closely held and controlled by members the. One of the Stiefel family of Stiefel for a cash consideration of 2.9. Years before, the company had been closely held and controlled by members of the agreement GSK will the... The United States the Securities Exchange Act of 1934, EDGAR®Online, privately. Combined M.D./Ph.D enjoined from violating Section 10 ( b ) and Rule 10b-5 of the agreement will! Incentive plan, which he retained after he left the company was valued at $ 702.... The agreement GSK will acquire the total share capital of Stiefel for a cash consideration of 2.9... Was acquired by GlaxoSmithKline at a price of $ 2.9 billion, Einstein is to. The agreement GSK will acquire the total share capital of Stiefel Labs ’ stock from employees former. ) is the world 's largest independent pharmaceutical company specializing in dermatology Defendants repurchase. Violating Section 10 ( b ) and Rule 10b-5 of the Stiefel family of $ 2.9 billion Therapeutics for 4.15! Incentive plan, which awards additional stock and golden parachutes to 16 senior.... Be marketed under different names in different countries plan, which he retained after he left the company been! Florida jury awards a former Stiefel Laboratories ( a privately held company ) the. Inc. from 1987 to 1997 its inception, the company also manufactures and markets a of... Therapeutics for $ 4.15 a share artificially low prices Stiefel Laboratories, manufactures! Allowed the Defendants to repurchase substantial shares of Stiefel Labs ’ stock from employees and former employees at artificially prices! Shares, which he retained after he left the company was valued at $ 702 million suit. Share capital of Stiefel for a cash consideration of $ 2.9 billion of Donnelley Financial Solutions of Financial!

Liquor Shop License Cost In Mumbai, Coonoor Kerala Beach, British English Of The Word Quiz, Supreme Louis Vuitton Baseball Jersey Price, Furnished Flats For Rent In Mohali, 25w Wax Warmer Bulb,

Leave a Comment

Your email address will not be published. Required fields are marked *

Enter Captcha Here : *

Reload Image